Literature DB >> 2306252

Amino acid sequence of ghilanten: anticoagulant-antimetastatic principle of the South American leech, Haementeria ghilianii.

D T Blankenship1, R G Brankamp, G D Manley, A D Cardin.   

Abstract

This study reports the amino acid sequence of ghilanten, an anticoagulant-antimetastatic principle of the hematophagous leech, Haementeria ghilianii. Ghilanten consists of 119 amino acids with twenty cysteines and a consensus sequence for heparin-binding at its carboxyl-terminus. Arginine-34 represents the reactive residue involved in the active-site inhibition of trypsin and Factor Xa. Immunoreactivity data suggest that heterogeneity among ghilantens is due in part to amino acid substitutions at their carboxyltermini.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306252     DOI: 10.1016/0006-291x(90)91020-s

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa.

Authors:  R Lapatto; U Krengel; H A Schreuder; A Arkema; B de Boer; K H Kalk; W G Hol; P D Grootenhuis; J W Mulders; R Dijkema; H J Theunissen; B W Dijkstra
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

2.  Mast cell tryptases: examination of unusual characteristics by multiple sequence alignment and molecular modeling.

Authors:  D A Johnson; G J Barton
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

3.  Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood-sucking leech Haementeria ghilianii.

Authors:  S Finney; L Seale; R T Sawyer; R B Wallis
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

4.  Evaluation of proposed modes of binding of (2S)-2-[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxy]phenyl]-3-(7-am idino- 2- naphthyl)propanoic acid hydrochloride and some analogs to factor Xa using a comparative molecular field analysis.

Authors:  R J Vaz; L R McLean; J T Pelton
Journal:  J Comput Aided Mol Des       Date:  1998-03       Impact factor: 3.686

5.  Site-directed mutagenesis of the leech-derived factor Xa inhibitor antistasin. Probing of the reactive site.

Authors:  K J Hofmann; E M Nutt; C T Dunwiddie
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

Review 6.  Leech therapeutic applications.

Authors:  A M Abdualkader; A M Ghawi; M Alaama; M Awang; A Merzouk
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

Review 7.  Medicinal leech therapy-an overall perspective.

Authors:  Ali K Sig; Mustafa Guney; Aylin Uskudar Guclu; Erkan Ozmen
Journal:  Integr Med Res       Date:  2017-08-10

8.  The Origin and Evolution of Antistasin-like Proteins in Leeches (Hirudinida, Clitellata).

Authors:  Rafael Eiji Iwama; Michael Tessler; Mark E Siddall; Sebastian Kvist
Journal:  Genome Biol Evol       Date:  2021-01-07       Impact factor: 3.416

9.  Diversity and selective pressures of anticoagulants in three medicinal leeches (Hirudinida: Hirudinidae, Macrobdellidae).

Authors:  Sebastian Kvist; Gi-Sik Min; Mark E Siddall
Journal:  Ecol Evol       Date:  2013-03-05       Impact factor: 2.912

10.  Isolation and Characterization of Poecistasin, an Anti-Thrombotic Antistasin-Type Serine Protease Inhibitor from Leech Poecilobdella manillensis.

Authors:  Xiaopeng Tang; Mengrou Chen; Zilei Duan; James Mwangi; Pengpeng Li; Ren Lai
Journal:  Toxins (Basel)       Date:  2018-10-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.